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ABSTRACT
Mochammad Sja’bani, Mohammad Ismadi, Siti Dawiesah Ismiati, Raja Pingkir Sidabutar, Djoko Rahardjo -
The therapeutic effect of citrus aurantifolia swingle in idiopathic hypocitraturic calcium nephrolithiasis
Background: Hypocitraturia is one of the main risks of stone appearance or renal stone recurrence that is
easily interfered. A sphere citrus fruit (Citrus aurantifolia Swingle) was reported to contain the highest
citrate compared to other citrus fruits.
Aims: We aimed to determine the effect of Citrus aurantifolia Swingle on the management of hypocitraturia,
compared with potassium citrate.
Materials and Methods: Seventy two patients with idiopathic calcium renal stone with hypocitraturia were
randomly divided into two groups, therapy and placebo groups. The first group was given potassium citrate
treatment (2x20 mEq/day), while the second one was given 2x1.5-g pure lactose. After 6 months,
patients without stomachache complaints were given 40ml citrus juice diluted in 2 glasses of water, taken
immediately after dinner for 10 days. Observation was done on risk factors in urine collected for 8, 16 and
24-hours, including volume, pH, potassium, magnesium, oxalate, citrate, calcium, sodium, phosphate,
sulphate, uric acid, ureum and creatinine. The setting of this study was 1 hospital in Yogyakarta and 2
hospitals in Jakarta.
Results:  The increase of urine volume, pH, level and total citrate value, level and total potassium, and the
decrease of calcium ratio to citrate urine. The changes of those metabolite levels could lessen the chance
of colic and hematuria complaints, as seen after 6 months administation of potassium citrate. Similar
results were obtained from the administration of citrus juice, except for calcium level, which was not
decreased.
Conclusion: The administration of potassium citrate 2x20mEq/day in 6 months improved patient’s complaints
and occurrence of renal colic, while consumption of Citrus aurantifolia Swingle in idiopathic calcium renal
stone with hypocitraturia was concluded to increase the urine volume, pH level and total citrate value,
level and total potassium, and the decrease of calcium ratio to urine citrate.
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ABSTRAK
Sja’bani - Pengaruh pemberian perasan jeruk nipis (Citrus aurantifolia swingle) pada penderita batu ginjal
kalsium idiopatik dengan hipositraturia
Latar belakang: Hipositraturia merupakan salah satu factor risiko yang penting untuk timbilnya batu ginjal
kambuh yang mudah dilakukan intervensi. Jeruk nipis local buah sitrus (Citrus aurantifolia swingle) dilaporkan
mempunyai kandungan sitrat tertinggi diantara buah sitrus.
Tujuan: Menentukan pengaruh pemberian perasan jeruk nipis (Citrus aurantifolia swingle) pada terapi
hipositraturia disbanding dengan kalium sitrat.
Bahan dan Metode: Dilakukan uji klinik acak terhadap 72 penderita batu ginjal kalsium idiopatik dengan
hipositraturia terbagi dalam dua kelompok, kelompok terapi dan kelompok placebo. Kelompok pertama
diberikan terapi kalium sitrat (2x20 mEq/hari), sedang kelompok dua diberikan 2x1,5g lactose murni.
Sesudah 6 bulan penderita tanpa keluhan nyeri lambung diberikan 40 ml perasan sitrus diencerkan dalam
2 gelas air diminum sesat sesudah makan malam selama 10 hari. Pengamatan terhadap factor risiko air
kemih penampungan dalam 8, 16 dan 24 jam, meliputi volume pH, kalium, magnesium, oksalat, sitrat,
kalsium natrium, phosphate, sulphat, asam urat, ureum dan kreatinin. Penelitian dilakukan di satu rumah di
Yogyakarta dan dua rumah sakit di Jakarta.
Hasil: Ditemukan kenaikan dalam volume PH, nilai dan totl sitrat, nilai dan total kelium, dan penurunan
rasio kalsium terhadap sitrat air kemih. Perubahan nilai metabolik diduga dapat mengurangi keluhan kolik
dan hematuria yang terjadi sesuah pemberian kalium sitrat selama 6 bulan. Hasilnya serupa dengan pemberian
perasan sitrus, dengan tanpa penurunan nilai kalsium.
Simpulan: Pemberian kalium sitrat 2x20mEq/hari selama 6 bulan mengurangi kejadian keluhan kolik
penderita, sedang mengkonsumsi  Citrus aurantifolia swingle pada batu ginjal kalsium idiopatik dengan
hipositraturia dapat meningkatkan air kemih dalam volume, nilai pH, nilai dan total sitrat, nilai dan total
kalium, serta menurunkan rasio kalsium terhadap sitrat air kemih.
INTRODUCTION
Nephrolithiasis can be classified into renal stone
and bladder stone. Renal stones are the most causes
of urinary tract abnormality. The proportion of renal
stone in Indonesia is closed to those of developed
countries, such as The United States, Europe and
Australia. In two cities of Java in Indonesia,
Yogyakarta and Semarang, the proportion of renal
stone has relatively been increasing compared to
the proportion of bladder stone since 1974 and 1979
(our unpublished data).  Most renal stones consist
of calcium oxalate and phosphate or both (65-
85%).1
Prevention of a new stone appearance was
aimed to avoid risk factors. Some clinical test data
showed a recurrence in control group without
intervention around 10-23%/year. Risk factors such
as hypercalciuria, hyperoxaluria, hypocitraturia and
hyperuricosuria were reported as the main
predisposition factors of calcium renal stone
occurrence.1,2 The role of dietary oxalate in the
pathogenesis of calcium oxalate nephrolithiasis is
unclear. Significant variation can exist between
individuals with respect to the alimentary absorption
of oxalate.3 High level of sodium, sulphate,
phosphate and low level of magnesium in the urine
also played a role in the occurrence of calcium renal
stone.4,5  The main risk factor easily interfered was
hypocitraturia. Hypocitraturia, which could help
augment stone formation, could be caused by
acidosis, high protein diet and chronic diarrhea.6,7
Hypocitraturia could be burdened by the presence
of high sodium diet intake.6 The latter was also
reported to increase calcium excretion.
The metabolism of sulfur-containing amino
acids in animal flesh generates sulfuric acid. As
such, dietary animal protein represents an acid load
that increases urinary calcium excretion and
reduces urinary tract excretion. Dietary protein may
also lead to an increase in calcitriol production
(possibly induced by an increase in renal mass). A
positive association between animal protein
consumption and new kidney stone formation has
been shown in men but not women.8
Renal stone growth was frequently considered
occurring in the evening due to food composition,
lack of activity and long rest.7 Citrate excretion in
the urine was considered to be highest in the late
afternoon and lowest in the morning.5,7,9  Oxalate
and urinary citrate examination to manage renal
stone case was reported (Sja’bani M et al, 1993,
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unpublished data), whereas the follow-up study was
never yet reported in Indonesia. An easy, practical
and exact method of urine collection should be
determined, such as past 22.00-06.00 compared to
24-hour urine collection.
It was considered that the low level of citrate
in urine really played a role as a risk factor for
idiopathic calcium renal stone to appear, mainly
oxalate calcium stone and phosphate calcium stone.
The low proportion of citrate level in urine was found
frequently in idiopathic calcium stone patients.10-13
The efforts to increase urine citrate level on renal
stone patients with idiopathic calcium type was done
at non-random and without comparison. Clinical
trial by comparing calcium renal stone patients with
hypocitraturia with 12 capsules of potassium citrate
divided into 3 dosages/day showed discomfort to
most patients.14  Potassium citrate administration
was reported to irritate the stomach. Potassium
citrate administered in an empty stomach or given
at mealtime was reported to have no compositional
difference in urine.15 The alkali and citrate excretion
changes in urine was reported to have reached its
peak 2 hours after oral intake and could decrease
gradually, and it could be concluded that drug
administration with large dosage should be
thoroughly examined and administered in the
morning and afternoon.7,9,16  Still, once daily dosage
administration was hoped to increase the patient’s
obedience.
Since potassium citrate material was difficult
to obtain and relatively expensive, a cheaper and
easier alternative should be sought. A sphere citrus
fruit (Citrus aurantifolia Swingle) was reported
as a fruit easily and cheaply obtained, containing
the highest citrate compared to other citrus fruits
such as oranges (Citrus sinensis Osb), mandarins
(Citrus nobilis Lour), and lemons (Citrus
limonium). The citrate content in a citrus fruit was
more than 10 times compared to citrate in a
mandarin (Sja’bani M et al, 1993, unpublished data).
Lemon juice administration in calcium stone patients
with hypocitraturia was reported,13 while the study
on citrus fruit as an easy and cheap plantation to
replace potassium citrate in reducing renal stone
risk factor, was not yet reported.
In this study, we investigated the effects of
potassium citrate and citrus juice in renal stone
complaints and metabolite change in urine from 72
patients with renal stone with hypocitraturia past
stone removal by surgery, percutaneous nephrolitho-
tomy (PCN) or lithotripsy.
MATERIALS AND METHODS
Experimental study was done with a double
blind randomized clinical trial plan. In the study of
citrus administration, a trial study plan was used
before and after administration. The study
population was idiopathic calcium renal stone
patients with hypocitraturia (without primary
abnormality; such as hyperparathyroidism, normal
calcium and blood uric acid levels, and stone
patients accompanied by a history of stone output)
past stone removal by surgery, percutaneous
nephrolithotomy (PCN) or lithotripsy. They were
patients with clean stone or without complaints of
broken stone with a diameter of less than 5 mm,
patients who did not suffer from systemic disease
that needed treatment (such as primary hyper-
parathyroidism, sarcoidosis, myoma, renal tubulus
acidosis and intestine shortening syndrome/had
intestine surgery) and patients who were not in
pharmacological treatment for stone disease. They
were proofed to be stone free by intravenous
pielography X-ray, and citrate level was still less
than 320 mg in 24-hour urine.
Seventy two patients from 2 centers in Jakarta,
namely Cikini, Mediros and Sumber Waras Hospital,
and 1 in Yogyakarta namely Panti Rapih Hospital
were taken purposively. They were divided into
therapy and placebo groups. The first group was
given potassium citrate treatment (extra pure tri-
potassium citrate monohydrate DHB, Ph Eur, BP,
USP, FCC, E 332 MERCK 64271 Darmstadt,
Germany) with a dosage of 2x20 mEq/day each.
The second group was given 2x1.5-g pure lactose.
Both groups were advised to lessen salt intake, or
to consume salty food.  The habit of protein intake
in both groups was advised not to be changed. After
6 months, patients without stomachache complaints
were given 2 pieces of citrus juiced (diameter >
4.5 cm) or more than 40 ml, diluted in 2 glasses of
water, taken after evening meals. Observation was
done on risk factors in urine collected for 8, 16 and
24-hour, including volume, pH, potassium,
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magnesium, oxalate, citrate, calcium, sodium,
phosphate, sulphate, uric acid, ureum and creatinine.
The study variable consisted of independent
and dependent variables. Independent variable
consisted of potassium citrate and citrus juice
administration. The independent variable was
correlated with dependent variable that were renal
stone complaints consisted of colic or renal pain,
spontaneous stone output and hematuria. The other
dependent variable in urine were pH, volume,
magnesium, citrate, sulphate, oxalate, phosphate,
calcium, uric acid, potassium, creatinine, sodium and
ureum. Dependent variable in urine could be
assumed as intermediate variable to dependent
variable renal stone complaints.
Following the urine volume measurement, a pH
meter microcomputer Hanna type HI 9023 was
used to measure the pH.  Parathormone level blood
serum (intact parathormone/immunoreactive
parathyroid hormone iPTH), the level of potassium,
sodium (with burnt photometry) calcium inorganic
phosphate and magnesium serum (photometry)
were examined. Examinations on enzymatic uric
acid, ureum, and creatinine in serum and urine were
also done. Potassium, sodium, magnesium and
calcium urine levels were examined with, as well
as spectrophotometer examination for oxalate by
Hodgkinson and Williams, citrate by Camp and
Farmer and spectrophotometer for sulphate and
phosphate.
Patients sent their urine every 3 months, which
were obtained by collecting urine from morning past
06.00 and retained until 22.00, while the second
urine was retained past 22.00 until 06.00. The
collected urine was divided into 3 small bottles, 2
of them were indicated with a label of urine past
06.00 until 22.00 and 1 bottle with urine past 22.00
until 06.00. Twenty four hours retained urine volume
was measured by mixing the retained morning and
afternoon urine. Its pH value was also determined.
We also provided 6 small bottles for the
collected urine. Two bottles contained toluene 0.5
ml (for citrate examination), two bottles contained
solid hydrochloride 0.4 ml (for oxalate, magnesium,
calcium, potassium, natrium, phosphate and sulphate
examination) and two bottles contained no
preservative. Each of the bottles was filled with
urine 50 ml from retained morning and evening
urine.
This study lasted for 6 months to observe
potassium citrate administration and 10 days for
citrus juice. Citrus juice was given after the study
lasted 6 months, in patients without stomachache
complaints. Each patient was reexamined and asked
to bring the remainder of medicine. Study was done
to know the urine composition level.
Chi-square (X2-test) was used to know the
proportion of renal stone occurrence after
potassium citrate was administered 2x20 mEq/day
or placebo used.  Independent t-test was used to
know the influence of potassium citrate
administration 2x20 mEq/day or placebo in urine
past 22.00 until 06.00; past 06.00 until 22.00 and
24-hours.  Correlated analysis was done to know
how large was the correlation of each risk factor
in the urine towards the proportion of renal stone
complaint occurrence. Logistic regression analysis
was done to identify the main risk factor (odd ratio
value) that had a chance of renal stone complaints.
Paired t-test was done to know the risk factor
changes caused by giving 2 citrus fruit juiced.
RESULTS AND DISCUSSION
Potassium Citrate Administration
There were no significant differences in sex,
family history and nausea complaints in the first 3
months, while colic complaints and hematuria were
found to increase in placebo group in the second 3
months, as seen in TABLE 1.
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Risk factor of urine Therapy group mean±SD Placebo group mean±SD 95% CI
6 months N=33 N=30 -2.25 ~ 0.01
Morning calcium 8.61±2.15 9.73±2.33
Morning total calcium 103.15±35.55 111.93±35.13 -26.61 ~ 9.05
Evening calcium 8.20±1.94 9.96±2.33 -2.84 ~ -0.69
Evening total calcium 63.95±27.30 77.80±28.64 -27.95 ~ 0.25
24 hour calcium 8.44±1.8 9.83±2.30 -2.46 ~ -0.31
24 hour total calcium 167.09±58.21 189.72±61.69 -52.84 ~ 7.58
Morning potassium 177.46±43.33 112.61±33.25 45.25 ~ 84.46
Morning total potassium 2077.55±542.01 1291.76±482.86 526.14 ~ 1045.44
Evening potassium 177.37±45.91 111.21±36.56 45.10 ~ 87.20
Evening total potassium 1344.59±559.95 851.27±355.73 254.24 ~ 732.41
24 hour potassium 176.92±37.55 112.07±26.55 48.56 ~ 81.15
24 hour total potassium 3422.12±892.27 2143.03±683.06 875.74 ~ 1682.49
SD: standard deviation CI: confidence interval n= number of patients
TABLE 1. Sex, stone history and renal stone complaints on treatment group vs placebo group at baseline,
after 3 and 6 months
Variable Treatment Placebo N
group (%) group (%)
Baseline N=37 N=35
Sex (M/F) 67.6/32.4 74.3/25.7 0.609
Stone history 45.9 34.3 0.345
3 months N=35 N=32
Sex (M/F) 68.6/31.4 71.9/28.1 0.796
Stone history 42.9 34.4 0.617
Colic history 0 6.3 0.224
Hematuria history 0 6.3 0.224
Spontaneous stone output 0 0 -
6 months N=33 N=30
Sex (M/F) 69.7/30.3 70.0/30.0 1.000
Stone history 42.4 36.7 0.797
Colic history 9.1 33.3 0.028
Hematuria history 9.1 36.7 0.014
Spontaneous stone output 6.1 23.3 0.073
The evening calcium level and 24-hour after 3
and 6 months in potassium citrate therapy group
were found significantly smaller compared to
evening and 24-hour calcium level in placebo group
(P<0.05). The value of total calcium in the morning,
evening and 24-hours in the therapy group tended
to be smaller compared to the total calcium value
in the morning, evening and 24-hours in placebo
group, although it the difference was not significant
(TABLE 2).
TABLE 2. Risk factors of calcium and potassium after 6 months treatment therapy group vs placebo group
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Barcelo et al. (1993) reported that pH value
and total urine citrate were significantly higher
caused by the administration of 60 mEq/day
potassium citrate in 3 and 6 months compared to
placebo.15  Other reports in the increase of total
citrate value and urine pH were reported to be
caused by sodium citrate, calcium citrate and
magnesium citrate.17-23 Sakhaee et al. (1991)
reported that potassium citrate administration 80
mEq/day to eight calcium stone patients for 18 days
could raise pH urine value and total citrate urine
excretion and decreasing urine calcium excretion.24
Potassium citrate administration of 60 mEq for 4
weeks to 5 uric acid stone patients, increased citrate
level and decreased urine calcium level.17
Butz et al.(1984) and Preminger et al. (1988)
reported that the total value of calcium was smaller
after potassium citrate administration more than 3
months, based on an unrandomized study.18,21  The
low level of calcium in urine was necessary to
prevent stone formation.  The ratio of calcium molar
to citrate molar could be used to determine the
amount of free calcium to oxalate, phosphate
complex and formed urinary tract stone.25
The calcium ratio value to citrate in the
morning, evening and 24-hour therapy group was
found significantly smaller compared to calcium
ratio value to citrate in placebo group after 3 and 6
months (TABLE 3 and TABLE 4).  Calcium ratio
value to sulphate and calcium ratio to phosphate
remained smaller significantly in the evening urine
(from 22.00 until 06.00), as seen from the result of
the first and second 3 months. Calcium to citrate
excretion ratio value was significantly higher in
stone patients compared to normal control.26,27
TABLE 3. Risk factor of pH and citrate after 3 months on treatment group vs placebo
Urine risk factor Treatment groupmean ± SD Placebo groupMean ± SD 95% CI
3 months N=35 N= 32
Morning pH 6.24±0.53 5.55±0.36 0.47 ~ 0.91
Evening pH 6.33±0.53 5.48±0.33 0.63 ~ 1.06
24 hours pH 6.28±0.52 5.53±0.35 0.53 ~ 0.96
Morning citrate 24.19±9.763 14.51±4.08 6.06 ~ 13.31
Morning total citrate 273.62±113.92 157.18± 50.45 73.77 ~ 159.12
Evening citrate 24.78±5.60 14.29±4.15 9.06 ~ 13.91
Evening total citrate 183.23± 60.75 98.01±36.66 60.90 ~ 109.54
24 hours citrate 24.64±6.41 14.39±3.44 7.76 ~ 12.75
24 hours total citrate 456.85±140.99 255.19±73.29 147.23 ~ 256.09
SD: standard deviation CI: confidence interval
Citrus Juice Administration
Twenty-seven out of 33 patients in therapy
group and 26 out of 30 patients in placebo group
received 2 citrus fruit juiced of more than 40 ml
and diluted in 2 glasses for 10 days.  Four patients
from therapy and 2 from placebo were dropped
from citrus juice administration observation due to
their disobidience. The final number of patients from
therapy group was 27 patients and placebo group
was 26 patients. There were 17 patients with
hypocitraturia, which all were from placebo group.
The evening volume and total 24-hour urine in
therapy and placebo group (P<0.001) presented
significant increase. The pH value in therapy group
was significantly lower in morning urine (P<0.05).
The pH value in evening and 24 hours urine was
not significantly different.
The administration of citrus juice to therapy group
resulted in the reduction in citrate level in morning
urine (P<0.05), evening and 24-hour (P<0.001). The
total amount of citrate was significantly smaller in
morning urine (P<0.05). In placebo and hypocitraturia
group, after citrus juice was given, level and total value
of citrate was significantly greater in the morning,
evening and 24-hour urine (P<0.01). An increase of
total citrate value showed a renal stone risk factor
reduction in placebo and hypocitraturia group
(TABLE 5 and TABLE 6).
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TABLE 4. Risk factor of pH and citrate after 6 months treatment therapy group vs placebo group
Risk factor of urine Therapy groupMean ± SD      Placebo groupMean ± SD 95%CI
6 months N=33 N=30
Morning calcium 8.61±2.15 9.73±2.33 -2.25 ~ 0.01
Morning total calcium 103.15±35.55 111.93±35.13 -26.61 ~ 9.05
Evening calcium 8.20±1.94 9.96±2.33 -2.84 ~ 0.69
Evening total calcium 63.95± 27.30 77.80± 28.64 -27.95 ~0.25
24 hour calcium 8.44±1.98 9.83±2.30 -2.46 ~ 0.31
24 hour total calcium 167.09±58.21 189.72±61.69 -52.84 ~ 7.58
Morning potassium 177.46±43.33 112.61±33.25 45.25 ~ 84.46
Morning total potassium 2077.55±542.01 1291.76±482.86 526.14 ~ 1045.44
Evening potassium 177.37±45.91 111.21±36.56 45.10 ~ 87.20
Evening total potassium 1344.59±559.95 851.27±355.73 254.24 ~ 732.41
24 hour potassium 176.92±37.55 112.07±26.55 48.56 ~ 8.15
24 hour potassium 3422.15±892.27 2143.03±683.06 875.74 ~ 1682.49
SD: standard deviation CI: confidence interval n= number of patients
Citrus juice administration decreased oxalate
level value in the evening and 24- hour urine
significantly in therapy and placebo group, while
evening urine oxalate level value was significantly
smaller in hypocitraturia group. There was no
significant difference in the total oxalate, calcium,
magnesium, sodium value after citrus administrations
in three groups. A significant smaller magnesium level
value was found in evening and 24 hour urine in three
groups (P<0.001). The  urine potassium level value in
the morning, the evening and 24 hours and total
potassium value in the morning and 24-hour in the
group who received therapy decreased significantly
after receiving citrus juice. Citrus juice administrati-
on increased the level and total potassium value in
morning, evening and 24 hours urine in placebo and
hypocitraturia group significantly (P<0.001). An
increase of potassium due to citrus juice administrat-
ion caused an increase of pH value in urine with
the presence of potassium, calcium, magnesium and
sodium in urine. Sodium urine level value in the
evening and 24 hour were found significantly
smaller in therapy group (P<0.001) and placebo
group (P<0.05), but total sodium value was found
with no difference in therapy and placebo groups
before and after citrus juice administration (data
not shown).
Sulphate and phosphate level value were
significantly smaller (P<0.05) in the evening and
24-hour urine in therapy group, while in placebo
and hypocitraturia groups, the phosphate urine level
value was smaller. The total sulphate and phosphate
values in all urine collection were found to be not
significant. A decrease of sulphate and phosphate
level was considered to be advantageous to calcium
stone patients, although there was no significant
difference in total value. This was considered due
to urine volume changes. There was no significant
difference in uric acid level and total value in
morning, evening and 24-hour urine. There was no
significant difference in level and total ureum value
in the morning, evening and 24-hour urine, in
placebo and hypocitraturia groups, except for ureum
level value in 24-hour urine in placebo group was
significantly smaller (P<0.05). The creatinine level
value was smaller in evening and 24-hour urine in
therapy group and evening urine in placebo group.
There was no difference in total creatinine value in
all groups and in morning, evening and 24-hour urine
collection (data not shown).
The calcium ratio value to citrate in morning,
evening and 24-hour urine tended to increase.  The
ratio of calcium to citrate in morning, evening and
24-hour urine was significantly smaller in placebo
and hypocitraturia groups after citrus juice
administration (p<0.01). There was no significant
difference in the calcium ratio value to phosphate,
sulphate and creatinine in morning, evening and 24-
hour urine in therapy group (data not shown).
An increase of urine volume was reported to
decrease renal stone occurrence.28 The volume of
urine in patients with renal stone formation were
found less than 250-350 ml.29 The pH value of
morning urine was considered smaller as citrus juice
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was administered in the evening and such value was
equally obtainable with the administration of potassium
citrate 20 mEq. Citrus juice administration was
considered to influence urine changes in the evening.
A higher pH value in the morning, evening and 24
hour was found after the administration of citrus
juice in placebo and hypocitraturia groups (P<0.001)
(TABLE 7 and TABLE 8).
TABLE 7. Urine volume after 6 months of potassium citrate administration in treatment group vs placebo and
after 10 days of citrate administration in treatment group vs placebo in therapy, placebo and hypocitraturia.
Urine Risk Factors Treatment group (n=27) 95%CI    P
Beforemean ± SD Aftermean ± SD
Morning urine volume 1187.04±183.59 1201.11±175.05 -64.44 ~ 36.29 0.571
Evening urine volume 756.67±234.32 874.81±238.70 -147.47 ~ -8.83 <0.001
24 hours urine volume 1943.70±331.84 2075.93±304.37 -177.09 ~ -7.35 <0.001
Morning urine volume 1125.38±199.20 1158.08±186.44 -78.83 ~ 7.45 0.106
Evening urine volume 753.46±178.05 850.38±205.63 -140.97 ~ -88.83 <0.001
24 hours urine volume 18778.85±340.96 2008.46±345.00 -179.97 ~ -79.27 <0.001
Morning urine volume 1044.71±179.17 1098.24±176.79 -93.15 ~ -13.91 0.011
Evening urine volume 704.12±170.26 774.71±182.73 -127.10 ~ -14.08 0.018
24 hours urine volume 1748.82±313.09 1872.94±295.16 185.60 ~ -62.63 0.001
Urine Risk Factors Treatment                                              95%CI
group (n=27)
Beforemean±SD Aftermean±SD P
Morning pH 6.31±0.49 6.21±0.37 0.002 ~ 0.22 0.047
Evening pH 6.12±0.99 6.23±0.39 -0.46 ~ 0.24 0.526
24 hours pH 6.30±0.49 6.23±0.32 -0.02 ~ 0.17 0.134
Placebo group (N=26)
Morning pH 5.66±0.31 6.13±0.32 -0.60 ~ -0.35 <0.001
Evening pH 5.64±0.35 6.26±0.29 -0.75 ~ -0.48 <0.001
24 hours pH 5.64±0.33 6.20±0.29 -0.68 ~ -0.43 <0.001
Hypocitraturia (N=17)
Morning pH 5.64±0.29 6.04±0.33 -0.55 ~  -0.25 <0.001
Evening pH 5.66±0.34 6.19±0.31 -0.69 ~  -0.36 <0.001
24 hours pH 5.64±0.30 6.12±0.31 -0.64 ~  -0.33 <0.001
TABLE 8. Urine pH after 6 months of potassium citrate administration in treatment group vs placebo and after 10 days of
citrate administration in treatment group vs placebo in therapy, placebo and hypocitraturia
An increase of pH and urine citrate and a
decrease of calcium ratio value to citrate were also
found in citrus juice administration. Stomachache
side effect and nausea were not found in the two
groups of citrate and placebo for 6 months and citrus
juice administration for 10 days, when taken while
eating or after meals.
Based on this study we suggested the
consumption of potassium citrate 2 x 20 mEq/day
in more than 6 months for idiopatic calcium renal
stone post removal patients with hypocitraturia. This
is meant to maintain optimal condition in urine, thus
decreasing renal stone complaints. Since we found
similar results in metabolite changes in the urine of
hypocitraturic nephrolithiasis patients after the
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consumption of citrus juice, we also suggest such
patients to consume 2 pieces of citrus juice and
diluted in 2 glasses of water to be taken immediately
after dinner more than 10 days.
CONCLUSION
The administration of potassium citrate
2x20mEq/day in 6 months improved patient’s
complaints and occurrence of renal colic, while
consumption of Citrus aurantifolia Swingle in
idiopathic calcium renal stone with hypocitraturia
was concluded to increase the urine volume, pH
level and total citrate value, level and total
potassium, and the decrease of calcium ratio to urine
citrate. Such conditions decrease the reccurence
of renal stone in patients with post-stone removal.
The effect of citrus juice administration for longer
duration, as well as the influence of citrus juice
administration to patients for other types of renal
stones should be further examined.
REFERENCES
1. Parks JH & Coe FL. 1986. A urinary calcium-citrate
index for the evaluation of nephrolothiasis. Kidney Int.
30: 85-90.
2. Coe FL, Parks JH. & Asplin JR. 1992. The pathogenesis
and treatment of kidney stones. N. Engl. J. Med. 327:
1141-52.
3. Holmes RP, Assimos DG. 2004. The impact of dietary
oxalate on kidney stone formation. Urol Res.32:311-16.
4. Robertson WG, Peacock M, Heyburn PJ, Hanes FA &
Swaminathan R. 1981. The risk of calcium stone
formation in relation to affluence and dietary animal
protein. In Brockis, J.G., and Finlayson, B. (eds): Urinary
Calculus. PSG Publishing Company pp. 3 12.
5. Strauss AL, Coe F, Deutsch L & Parks JH. . Factors that
predict relapse of calcium nephrolithiasis during
treatment. A prospective study. Am. Journal Med, 1982;
72: 17-24.
6. Gordon EE & Sheps SG. . Effect of acetazolamide on
citrate excretion and formation of renal calculi. N. Engl.
J. Med, 1957; 256: 1215-19.
7. Obialo CI, Clayman RV, Matts JP, Fitch LL, Buchwald
H, Gillis M & Hruska KA. Pathogenesis of
nephrolithiasis post-partial ileal bypass surgey: case-
control study. Kidney Int. 1991; 39: 1249-54.
8. Curhan GC, Willet WC, Speizer F. Dietary factors and
the risk of incident kidney stones in younger women
(Nurses’ Health Study III). Arch Intern Med, 2004; 164:
885-91.
9. Robert M, Roux JO, Bourelly F, Boularan AM, Guiter
J & Monnier L. Circadian variations in the risk of urinary
calcium oxalate stone formation. Br. J. Urol. 1994; 74:
294-97.
10. Rudman D. Kutner MH, Redd SC, Waters WC, Gerron
GG & Bleier J. Hypocitraturia in calcium nephrolithiasis.
J. Clin. Endocrinol. Metab, 1982; 55: 1052-57.
11. Nicar MJ, Skurla C, Sakhaee K & Pak CYC. Low urinary
citrate excretion in nephrolithiasis. Urology, 1983; 21: 8
14.
12. Pak CYC & Peterson R. Successful treatment of
hyperuricosuric calcium oxalate nephrolithiasis with
potassium citrate. Arch. Intern. Med. 1986; 146: 863-
67.
13. Seltzer MA, Low RK, McDonald M, Shami GS & Stoller
ML. Dietary manipulation with lemonade to treat
hypocitraturic calcium nephrolithiasis. J. Urol. 1996;
156: 907-909.
14. Barcelo P, Wuhl O, Servitge E, Rousaud A & Pak CYC.
Randomized double-blind study of potassium citrate in
idiopathic hypocitraturic calcium nephrolithiasis. J. Urol,
1993; 150: 1761-64.
15. Pak CYC, Oh MS, Baker S & Morris JS. Effect of meal
on the physiological and physiochemical actions of
potassium citrate. J. Urol, 1991; 146: 803-805
16. Vahlensieck EW, Bach D & Hesse A. Circadian rhythm
of lithogenic substances in the urine. 1982; Urol. Res.
10: 195-203.
17. Sakhaee K, Nicar M, Hill K & Pak CYC. Contrasting
effects of potassium citrate and sodium citrate therapies
on urinary chemistries and crystallization of stone-
forming salts. Kidney Int, 1983; 24: 348-52.
18. Butz M, Karadzic G & Dulce HJ. Prevention of calcium
oxalate stones by alkaline treatment. Urol Res, 1984;
12: 40-44.
19. Pak CYC, Peterson R, Sakhaee K, Fuller C, Preminger
G & Reisch J. Correction of hypocitraturia and
prevention of stone formation by combined thiazide
and potassium citrate therapy in thiazide-unresponsive
hypercalciuric nephrolithiasis. Am. J. Med 1985; 79:
284-88.
20. Pak CYC & Fuller C. Idiopathic hypocitraturie calcium
oxalate nephrolithiasis successfully treated with
potassium citrate. Ann. Intern. Med,  1986; 104: 33-37.
21. Preminger GM, Sakhaee K & Pak CYC. Alkali action on
the urinary crystallization of calcium salts: contrasting
responses to sodium citrate and potassium citrate. J.
Urol. 1988; 139: 240-42.
22. Lemann J Jr, Gray RW & Pleuss JA. Potassium
bicarbonate, but not sodium bicarbonate, reduces urinary
calcium excretion and improves calcium balance in healthy
men. Kidney Int. 1989; 35: 688-95.
23. Hofbauer J, Hobarth K, Szabo N & Marberger M. Alkali
citrate prophylaxis in idiopathic recurrent calcium
oxalate urolithiasis - a prospective randomized study.
Brit. J. Urol. 1994; 73: 362-69.
24. Sakhaee K, Alpern R, Jacobson HR & Pak CYC.
Contrasting effects of various potassium salts on renal
208
Berkala Ilmu Kedokteran, Volume 39, No. 4, Desember 2007: 199-208
citrate excretion. J. Clin. Endocrinol. Metab. 1991; 72:
396-400.
25. Sakhaee K, Harvey JA, Padalino PK, Whitson P & Pak
CYC. The potential role of salt abuse on the risk for
kidney stone formation. J. Urol. 1993; 150: 310-12.
26. Nikkila M, Koivula T & Jokela H. Urinary citrate
excretion in patients with urolithiasis and normal
subjects. Eur Urol. 16: 1989; 382-85.
27. Cupisti A, Morelli E, Lupetti S, Meola M & Barsott G.
Low urine citrate excretions as main risk factor for
recurrent calcium oxalate nephrolithiasis in males.
Nephron, 1992; 61: 73-76.
28. Curhan GC, Wilett WC, Speizer FE, Spiegelman D &
Stampfer MJ. Comparison of dietary calcium with
supplemental calcium and other nutrients as factors
affecting the risk for kidney stones in women. Ann.
Intern. Med, 1997b; 126(7): 497-504.
29. Borghi L, Meschi T, Amato F, Briganti A, Novarini A &
Giannini A. Urinary volume, water and recurrences in
idiopathic calcium nephrolithiasis: A 5-year randomized
prospective study. J. Urol. 1996; 155: 839-43.
